English | Español
Patient Daily | Mar 25, 2026

Novartis acquires Synnovation breast cancer drug candidate in $2 billion deal
Patient Daily | Mar 25, 2026

FDA approves Imcivree for hypothalamic obesity after Rhythm Pharmaceuticals' trial setback
Patient Daily | Mar 25, 2026

Roche ends development of spinal muscular atrophy drug after trial results
Patient Daily | Mar 25, 2026

Truist Securities says biopharma may offer stability amid Middle East conflict
Patient Daily | Mar 25, 2026

Home-based chemotherapy proves to be safe and feasible in pilot study
Patient Daily | Mar 25, 2026

University of Michigan study finds urban living linked to lower first-time stroke risk
Patient Daily | Mar 25, 2026

Blood-based test may help guide breast cancer treatment for older women
Patient Daily | Mar 25, 2026

Study finds insulin caps lower out-of-pocket costs for Medicare beneficiaries

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'